Predicting successful biologics tapering in patients with inflammatory arthritis: Secondary analyses based on the BIODOPT trial.

Successful tapering is a reachable target for one in three patients with IA who is interested in reducing their biological therapy. No statistically significant predictors (besides allocation to tapering) were identified. Future research on mental health and tapering is encouraged.